Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ticarcillin sodium, quantity: 3.3 g (equivalent: ticarcillin, qty 3 g); potassium clavulanate, quantity: 119.2 g (equivalent: clavulanic acid, qty 100 mg) - injection, powder for - excipient ingredients: - timentin is indicated in the treatment of serious infections caused by susceptible strains of beta-lactamase producing organisms in the conditions listed below: septicaemia (and bacteraemia) cases caused by beta-lactamase producing organisms including strains of klebsiella pneumoniae, e.coli, staphylococcus aureus and pseudomonas aeruginosa. lower respiratory infections cases caused by beta-lactamase producing susceptible organisms including strains of staphylococcus aureus, haemophilus influenzae and klebsiella pneumoniae. bone and joint infections cases caused by beta-lactamase producing susceptible organisms including strains of staphylococcus aureus. skin and skin structure infections cases caused by beta-lactamase producing susceptible organisms including strains of staphylococcus aureus, klebsiella pneumoniae and e. coli. urinary tract infections cases caused by beta-lactamase producing susceptible organisms including strains of e.coli, klebsiella pneumoniae, pseudomonas aeruginosa and staphylococcus au

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - budesonide, quantity: 9 mg - tablet, modified release - excipient ingredients: stearic acid; lecithin; microcrystalline cellulose; hyprolose; lactose monohydrate; silicon dioxide; magnesium stearate; methacrylic acid copolymer; purified talc; titanium dioxide; triethyl citrate - cortiment prolonged-release tablets are indicated in adults for induction of remission in patients with mild to moderate active ulcerative colitis (uc) where 5-asa treatment is not sufficient or not tolerated.

United States - English - NLM (National Library of Medicine)

time-cap labs, inc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - do not use - with any other drug containing acetaminophen(prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. stop use and ask a doctor if pain persists for more than 10 days; fever persists for more than 3 days (unless directed by a doctor); condition worsens or new symptoms appear; redness or swelling is present. these could be signs of a serious condition. uses: temporarily releives mnor aches and pains due to: headache, backache, muscular aches, arthritis pain, colds, flu, fever, toothache, premenstrual cramps. pain reliever-fever reducer-antihistamine

United States - English - NLM (National Library of Medicine)

time cap laboratories, inc. - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - purpose pain reliever/fever reducer cough suppressant nasal decongestant uses temporarily relieves common cold/flu symptoms: - nasal congestion - cough due to minor throat & bronchial irritation - sore throat - headache - minor aches & pains - fever do not use - with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. - if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson's disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. stop use and ask a doctor if - you get nervous, dizzy or sleepless - pain, nasal congestion or cough get worse or last more than 7 days - fever gets worse or lasts more than 3 days - redness or swelling is present - new symptoms occur - cough comes back, or occurs

United States - English - NLM (National Library of Medicine)

time cap laboratories inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - purpose pain reliever/ fever reducer cough suppressant nasal decongestant uses temporarily relieves common cold/flu symptoms: - nasal congestion - cough due to minor throat & bronchial irritation - sore throat - headache - minor aches & pains - fever do not use - with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. - if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson's disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. stop use and ask a doctor if - you get nervous, dizzy or sleepless - pain, nasal congestion or cough get worse or last more than 7 days - fever gets worse or lasts more than 3 days - redness or swelling is present - new symptoms occur - cough comes back, or occur

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - budesonide 9mg;   - modified release tablet - 9 mg - active: budesonide 9mg   excipient: colloidal silicon dioxide ethanol hyprolose lactose monohydrate lecithin magnesium stearate methacrylic acid copolymer microcrystalline cellulose purified talc stearic acid titanium dioxide triethyl citrate - cortiment prolonged-release tablets are indicated in adults for induction of remission in patients with mild to moderate active ulcerative colitis (uc) where 5-asa treatment is not sufficient or not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

lifetime pharmaceuticals - ubidecarenone, quantity: 12 mg; paullinia cupana, quantity: 50 mg (equivalent: paullinia cupana, qty 250 mg; equivalent: caffeine, qty 7.5 mg); levocarnitine, quantity: 10 mg; coffea canephora, quantity: 200 mg (equivalent: coffea canephora, qty 1.4 g; equivalent: caffeine, qty 4 mg); achyranthes aspera, quantity: 100 mg (equivalent: achyranthes aspera, qty 11 g) - tablet, film coated - excipient ingredients: ethylcellulose; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; crospovidone; croscarmellose sodium; povidone; hypromellose; macrogol 8000; chlorophyllin-copper complex; titanium dioxide; carnauba wax - a combination of natural ingredients that may increase thermogenesis (metabolism) & boost energy. may assist weight loss in conjunction with a kilojoule/calorie controlled eating plan & exercise programme. caffeine can improve anaerobic exercise performance. q10 plays a vital role in the production of energy in the cells.

Australia - English - Department of Health (Therapeutic Goods Administration)

lifetime pharmaceuticals - zinc amino acid chelate, quantity: 20 mg (equivalent: zinc, qty 4 mg); panax ginseng, quantity: 50 mg (equivalent: panax ginseng, qty 150 mg); ginkgo biloba, quantity: 2 mg (equivalent: ginkgo biloba, qty 100 mg); tribulus terrestris, quantity: 37.5 mg (equivalent: tribulus terrestris, qty 1.875 g); avena sativa, quantity: 50 mg (equivalent: avena sativa, qty 500 mg); d-alpha-tocopheryl acid succinate, quantity: 3.7 mg; serenoa repens, quantity: 50 mg (equivalent: serenoa repens, qty 200 mg); vaccinium myrtillus, quantity: 15 mg (equivalent: vaccinium myrtillus, qty 1.5 g); epimedium sagittatum, quantity: 200 mg (equivalent: epimedium sagittatum, qty 4 g); paullinia cupana, quantity: 75 mg (equivalent: paullinia cupana, qty 375 mg; equivalent: caffeine, qty 16.5 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; povidone; hypromellose; carnauba wax; macrogol 400 - antioxidant properties. helps support immune function. may support cognitive function and assist with memory.

Australia - English - Department of Health (Therapeutic Goods Administration)

lifetime pharmaceuticals - sugar cane wax alcohols, quantity: 12 mg - tablet, uncoated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; croscarmellose sodium; brilliant blue fcf; colloidal anhydrous silica - sugar cane wax alcohols are obtained from the stems and leaves of sugar cane. they may assist in maintaining & managing normal healthy cholesterol levels.

Australia - English - Department of Health (Therapeutic Goods Administration)

lifetime pharmaceuticals - propolis, quantity: 400 mg/ml (equivalent: lead, qty 0.4 microgram/ml; equivalent: propolis resin, qty 200 mg/ml) - liquid, multipurpose - excipient ingredients: propylene glycol - antioxidant and free radical scavenging properties.propolis is a nutritional supplement helpful in supporting the immune system. may relieve the symptoms of colds & flu. when applied topically, propolis may be beneficial in bringing relief to minor skin irritations such as insect bites and stings as well as cuts & scratches.